ISRCTN ISRCTN17350364
DOI https://doi.org/10.1186/ISRCTN17350364
Protocol serial number N/A
Sponsor Mental Health Care Services Drenthe (Netherlands)
Funders Netherlands Organisation for Health Research and Development (ZonMw), Support Foundation (Stichting tot Steun) (Netherlands), Netherlands Care Cooperative (Zorgcoöperatie Nederland [formerly: De Open Ankh]) (Netherlands), The Per V. Petersen Foundation (Netherlands), National Foundation of Mental Health Care (Nationaal Fonds Geestelijke Volksgezondheid [NFGV]) (Netherlands)
Submission date
27/01/2006
Registration date
27/01/2006
Last edited
18/08/2009
Recruitment status
No longer recruiting
Overall study status
Completed
Condition category
Mental and Behavioural Disorders
Prospectively registered
Protocol
Statistical analysis plan
Results
Individual participant data
Record updated in last year

Plain English summary of protocol

Not provided at time of registration

Contact information

Dr J. Arends
Scientific

Department of Psychotic Disorders
Mental Health Care Services Drenthe
P.O. Box 30.007
Assen
9400 RA
Netherlands

Phone +31 (0)592 334883
Email Johan.Arends@GGZDrenthe.nl

Study information

Primary study designInterventional
Study designMulticentre randomised single blind active controlled parallel group trial
Secondary study designRandomised controlled trial
Scientific title
Study objectivesCould early treatment of prodromal symptoms prevent or postpone a psychotic relapse in schizophrenia?
Ethics approval(s)Received from local medical ethics committee
Health condition(s) or problem(s) studiedSchizophrenia, Schizophreniform disorder
InterventionThe Symptom Management Module (SMM), one of the independent living skills modules developed by the Los Angeles rehabilitation research group, is a psychosocial intervention to improve the capability of patients with schizophrenia to detect early warning signs (EWS) of a psychosis and to teach the patients to manage them.
Two treatment conditions (symptom management module [N = 46] versus self monitoring [N = 52]) and a comparison group (treatment as usual [N = 49]) in patients with schizophrenia or related psychotic disorders.
Intervention typeOther
Primary outcome measure(s)

Occurrence of a psychotic relapse: a worsening of at least two points on the CGI as assessed by psychiatrist and verified by researcher by a PANSS-interview within a week.

Key secondary outcome measure(s)

1. Hospitalisation
2. Psychopathology

Completion date01/01/2002

Eligibility

Participant type(s)Patient
Age groupNot Specified
SexNot Specified
Target sample size at registration147
Key inclusion criteria1. ICD-10 diagnosis of schizophrenia (F20) or schizoaffective disorder (F25)
2. A remitted state established by no more than one score of 4 on the positive scale of the PANSS
3. Necessary skills in Dutch language to undergo a training in Dutch
Key exclusion criteriaSubstance abuse
Date of first enrolment01/01/1997
Date of final enrolment01/01/2002

Locations

Countries of recruitment

  • Netherlands

Study participating centre

Department of Psychotic Disorders
Assen
9400 RA
Netherlands

Results and Publications

Individual participant data (IPD) Intention to shareNo
IPD sharing plan summaryNot provided at time of registration
IPD sharing plan